Literature DB >> 18712867

Quantitative microarray analysis of intact glycolipid-CD1d interaction and correlation with cell-based cytokine production.

Pi-Hui Liang1, Masakazu Imamura, Xiangming Li, Douglass Wu, Masakazu Fujio, Richard T Guy, Bing-Ching Wu, Moriya Tsuji, Chi-Huey Wong.   

Abstract

The protein CD1d binds self and foreign glycolipids for presentation to CD1-restricted T cells by means of TCR recognition and activates T(H)1 and T(H)2 chemokine release. In this study, a variety of glycolipid ligands were attached to a microarray surface and their binding with dimeric CD1d was investigated. An alpha-galactosyl ceramide (alpha-GalCer) bearing a carbamate group at the 6'-OH position was tethered to the surface, and the dissociation constant on surface with CD1d was determined to reflect the multivalent interaction. Competition assays were then used to determine the dissociation constants (Ki) of new and intact glycolipids in solution. The 4-fluorophenyloctanoyl-modified alpha-GalCer (18) was found to bind most strongly with CD1d (Ki 0.21 microM), 2 orders of magnitude stronger than alpha-GalCer and more than three times more selective than alpha-GalCer for IFN-gamma release from NKT cells. Various alpha-GalCer analogues were analyzed, and the results showed that the binding affinity of glycolipids to CD1d correlates well with IFN-gamma production but poorly with IL-4 secretion by NKT cells, suggesting that tighter binding ligands could bias cytokine release through the T(H)1 pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18712867      PMCID: PMC4455950          DOI: 10.1021/ja8012787

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  45 in total

1.  Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.

Authors:  N Singh; S Hong; D C Scherer; I Serizawa; N Burdin; M Kronenberg; Y Koezuka; L Van Kaer
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

2.  NKT cells and tumor immunity--a double-edged sword.

Authors:  M J Smyth; D I Godfrey
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

3.  Multivalent inhibition of AB(5) toxins.

Authors:  J M Gargano; T Ngo; J Y Kim; D W Acheson; W J Lees
Journal:  J Am Chem Soc       Date:  2001-12-26       Impact factor: 15.419

Review 4.  CD1 and lipid antigens: intracellular pathways for antigen presentation.

Authors:  J Jayawardena-Wolf; A Bendelac
Journal:  Curr Opin Immunol       Date:  2001-02       Impact factor: 7.486

Review 5.  The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids.

Authors:  S A Porcelli; R L Modlin
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

6.  Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.

Authors:  N Burdin; L Brossay; M Kronenberg
Journal:  Eur J Immunol       Date:  1999-06       Impact factor: 5.532

7.  Murine CD1d-restricted T cell recognition of cellular lipids.

Authors:  J E Gumperz; C Roy; A Makowska; D Lum; M Sugita; T Podrebarac; Y Koezuka; S A Porcelli; S Cardell; M B Brenner; S M Behar
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

8.  The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.

Authors:  S Hong; M T Wilson; I Serizawa; L Wu; N Singh; O V Naidenko; T Miura; T Haba; D C Scherer; J Wei; M Kronenberg; Y Koezuka; L Van Kaer
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

9.  Carbohydrate microarrays for the recognition of cross-reactive molecular markers of microbes and host cells.

Authors:  Denong Wang; Shaoyi Liu; Brian J Trummer; Chao Deng; Aili Wang
Journal:  Nat Biotechnol       Date:  2002-03       Impact factor: 54.908

10.  Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules.

Authors:  O V Naidenko; J K Maher; W A Ernst; T Sakai; R L Modlin; M Kronenberg
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

View more
  20 in total

1.  Divergent synthetic approach to 6''-modified α-GalCer analogues.

Authors:  Nora Pauwels; Sandrine Aspeslagh; Gerd Vanhoenacker; Koen Sandra; Esther D Yu; Dirk M Zajonc; Dirk Elewaut; Bruno Linclau; Serge Van Calenbergh
Journal:  Org Biomol Chem       Date:  2011-11-01       Impact factor: 3.876

Review 2.  Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells.

Authors:  James E East; Andrew J Kennedy; Tonya J Webb
Journal:  Med Res Rev       Date:  2012-12-13       Impact factor: 12.944

3.  Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy.

Authors:  Tai-Na Wu; Kun-Hsien Lin; Ya-Jen Chang; Jing-Rong Huang; Jing-Yan Cheng; Alice L Yu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

4.  Design of a covalently bonded glycosphingolipid microarray.

Authors:  Emma Arigi; Ola Blixt; Karsten Buschard; Henrik Clausen; Steven B Levery
Journal:  Glycoconj J       Date:  2011-11-22       Impact factor: 2.916

5.  Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.

Authors:  Xiangming Li; Masakazu Fujio; Masakazu Imamura; Douglass Wu; Sandhya Vasan; Chi-Huey Wong; David D Ho; Moriya Tsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-02       Impact factor: 11.205

Review 6.  A double-edged sword: the role of NKT cells in malaria and HIV infection and immunity.

Authors:  Sandhya Vasan; Moriya Tsuji
Journal:  Semin Immunol       Date:  2009-12-04       Impact factor: 11.130

7.  Microplate-based characterization of protein-phosphoinositide binding interactions using a synthetic biotinylated headgroup analogue.

Authors:  Denghuang Gong; Matthew D Smith; Debasis Manna; Heidi E Bostic; Wonhwa Cho; Michael D Best
Journal:  Bioconjug Chem       Date:  2009-02       Impact factor: 4.774

8.  Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node-Resident Dendritic Cells for a Robust Adjuvant Effect.

Authors:  Xiangming Li; Akira Kawamura; Chasity D Andrews; Jessica L Miller; Douglass Wu; Tiffany Tsao; Min Zhang; Deena Oren; Neal N Padte; Steven A Porcelli; Chi-Huey Wong; Stefan H I Kappe; David D Ho; Moriya Tsuji
Journal:  J Immunol       Date:  2015-08-07       Impact factor: 5.422

9.  Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection.

Authors:  Sandrine Aspeslagh; Marek Nemčovič; Nora Pauwels; Koen Venken; Jing Wang; Serge Van Calenbergh; Dirk M Zajonc; Dirk Elewaut
Journal:  J Immunol       Date:  2013-08-19       Impact factor: 5.422

Review 10.  Presentation of lipid antigens by CD1 glycoproteins.

Authors:  André Schiefner; Ian A Wilson
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.